早期干预服务与常规治疗对早期精神病疗效比较:系统综述、Meta分析与Meta回归
该系统综述与Meta分析纳入10项随机临床试验共2176例早期精神病患者,比较早期干预服务(EIS)与常规治疗(TAU)。结果显示EIS在全部13项可分析结局上均优于TAU,包括治疗中断、精神病性住院、症状严重程度及学业/就业参与。
要点
- EIS较TAU显著降低全因治疗中断(RR 0.70)和至少1次精神科住院(RR 0.74)。
- EIS在总症状、阳性症状和阴性症状严重程度上均显著优于TAU。
- EIS在治疗6、9-12和18-24个月时多数结局优势明显。
核心结论
- 在早期精神病患者中,EIS在所有可Meta分析的结局上均优于TAU。
- 结果支持为早期精神病患者资助并使用EIS。
研究设计与样本
- 系统综述、随机效应Meta分析及预设亚组与Meta回归分析,遵循PRISMA指南。
- 检索PubMed、PsycINFO、EMBASE和ClinicalTrials.gov至2017年6月6日,无语言限制。
- 纳入10项比较EIS与TAU的随机临床试验,共2176例患者,平均(SD)试验时长16.2(7.4)个月,范围9-24个月。
- 患者平均(SD)年龄27.5(4.6)岁,男性1355例(62.3%)。
主要发现
- EIS组全因治疗中断风险显著低于TAU组(RR 0.70;95% CI 0.61-0.80;P < .001)。
- EIS组至少1次精神科住院风险显著低于TAU组(RR 0.74;95% CI 0.61-0.90;P = .003)。
- EIS组学业或工作参与率显著高于TAU组(RR 1.13;95% CI 1.03-1.24;P = .01)。
- EIS组总症状严重程度(SMD -0.32;95% CI -0.47至-0.17;P < .001)、阳性症状(SMD -0.22;95% CI -0.32至-0.11;P < .001)和阴性症状(SMD -0.28;95% CI -0.42至-0.14;P < .001)均显著低于TAU组。
- EIS在治疗6、9-12和18-24个月时所有结局均显示优势,但18-24个月时一般症状严重程度和抑郁症状严重程度除外。
关键数值与推荐
- 共13项可Meta分析结局,EIS在治疗结束时均优于TAU。
- 共同主要结局为治疗期间全因治疗中断和至少1次精神科住院。
临床怎么用
- 临床应优先为早期精神病患者提供EIS以降低治疗中断和住院风险。
- EIS有助于改善症状严重程度并提高学业或工作参与。
- 政策层面应支持EIS的资助与实施。
局限性
- 平均试验时长16.2个月,范围9-24个月,长期结局未报告。
- 18-24个月时一般症状和抑郁症状严重程度未见EIS优势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The value of early intervention in psychosis and allocation of public resources has long been debated because outcomes in people with schizophrenia spectrum disorders have remained suboptimal. OBJECTIVE: To compare early intervention services (EIS) with treatment as usual (TAU) for early-phase psychosis. DATA SOURCES: Systematic literature search of PubMed, PsycINFO, EMBASE, and ClinicalTrials.gov without language restrictions through June 6, 2017. STUDY SELECTION: Randomized trials comparing EIS vs TAU in first-episode psychosis or early-phase schizophrenia spectrum disorders. DATA EXTRACTION AND SYNTHESIS: This systematic review was conducted according to PRISMA guidelines. Three independent investigators extracted data for a random-effects meta-analysis and prespecified subgroup and meta-regression analyses. MAIN OUTCOMES AND MEASURES: The coprimary outcomes were all-cause treatment discontinuation and at least 1 psychiatric hospitalization during the treatment period. RESULTS: Across 10 randomized clinical trials (mean [SD] trial duration, 16.2 [7.4] months; range, 9-24 months) among 2176 patients (mean [SD] age, 27.5 [4.6] years; 1355 [62.3%] male), EIS was associated with better outcomes than TAU at the end of treatment for all 13 meta-analyzable outcomes. These outcomes included the following: all-cause treatment discontinuation (risk ratio [RR], 0.70; 95% CI, 0.61-0.80; P < .001), at least 1 psychiatric hospitalization (RR, 0.74; 95% CI, 0.61-0.90; P = .003), involvement in school or work (RR, 1.13; 95% CI, 1.03-1.24; P = .01), total symptom severity (standardized mean difference [SMD], -0.32; 95% CI, -0.47 to -0.17; P < .001), positive symptom severity (SMD, -0.22; 95% CI, -0.32 to -0.11; P < .001), and negative symptom severity (SMD, -0.28; 95% CI, -0.42 to -0.14; P < .001). Superiority of EIS regarding all outcomes was evident at 6, 9 to 12, and 18 to 24 months of treatment (except for general symptom severity and depressive symptom severity at 18-24 months). CONCLUSIONS AND RELEVANCE: In early-phase psychosis, EIS are superior to TAU across all meta-analyzable outcomes. These results support the need for funding and use of EIS in patients with early-phase psychosis.
引用
- Correll CU, Galling B, Pawar A, et al. Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression. JAMA Psychiatry. 2018. PMID: 29800949. doi:10.1001/jamapsychiatry.2018.0623
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。